| name | endo-fha-educate-ocps-masking |
| description | This skill involves educating patients with functional hypothalamic amenorrhea who use oral contraceptive pills for contraception that the pills may conceal the return of spontaneous menses and that bone loss can persist if an energy deficit remains. Use when a clinician says, “Let’s explain how OCPs might hide her recovery,” or when hearing triggers such as “Warn her OCPs can mask menses” or “Tell her bone loss may persist despite OCPs if she stays underweight.” |
Educate patients on OCPs masking menses and ongoing bone loss if energy deficit persists
STEP 1 — Gather Information
Confirm diagnosis of functional hypothalamic amenorrhea (FHA) and document current OCP use for contraception (not for menses or BMD). Assess energy deficit: weight/BMI, caloric intake vs. expenditure, exercise volume, menstrual pattern, and prior bone density if available.
STEP 2 — Rule In / Rule Out
Is the patient using OCPs solely for contraception?
- Yes → Proceed to STEP 3.
- No (OCPs used to induce menses or improve BMD, or not using OCPs) → Education specific to OCPs masking menses/bone loss not indicated; address other management.
STEP 3 — Classify or Stratify
Determine if an energy deficit persists:
- Energy deficit present (e.g., BMI <18.5, weight <90% expected, excessive exercise, low intake) → OCPs may mask menses and bone loss likely continues.
- No energy deficit (weight stabilized, intake matches expenditure) → OCPs may still mask menses, but bone loss less likely; focus on menses return monitoring.
STEP 4 — Decide
Educate the patient that OCPs can hide the return of natural menses and that bone loss may continue if the energy deficit is not corrected. Advise monitoring for menses after OCP discontinuation, consider repeat DXA if risk factors persist, and prioritize correcting energy imbalance via nutrition, reduced exercise, and psychological support.
Clinical Guardrails / Mimics / Pitfalls
Do not rely on OCPs to induce menses or improve BMD in FHA. Do not assume normal menses have resumed while the patient remains on OCPs. Do not overlook ongoing bone loss if weight or energy balance remains abnormal. Avoid prescribing OCPs solely for menstrual regulation in FHA without addressing underlying energy deficit.
Concrete Clinical Example
A 20‑year‑old distance runner presents with FHA, BMI 17.2, runs 60 mi/week, and takes OCPs for contraception. She reports no menses for 9 months. Educate her that OCPs may be masking the return of menses and that bone loss may persist due to her ongoing energy deficit; recommend gradual weight gain, reduce mileage, obtain a DXA scan, and reassess menses after OCP cessation.
Source: Functional Hypothalamic Amenorrhea: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2017, DOI:10.1210/jc.2017-00131
